Analystreport

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its price target lowered by analysts at Needham & Company LLC from $95.00 to $86.00. They now have a "buy" rating on

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com